Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 253
- Locations
- 1
- Primary Endpoint
- sustained implantation rate
Study Overview
Brief Summary
The proposed study is a single-blind randomized controlled trial which seeks to characterize implantation rates following embryo vitrification and subsequent warming with both slush nitrogen and liquid nitrogen. After warming, implantation rates and pregnancy outcomes will be assessed.
Detailed Description
The purpose of this study is to determine if slush nitrogen for embryo vitrification results in higher sustained implantation rates compared to the conventional use of liquid nitrogen. Routine ovarian stimulation, oocyte retrieval and embryology care will ensue. All blastocyst stage embryos will be randomized to either the control (liquid nitrogen) or intervention group (slush nitrogen) and vitrified after trophectoderm biopsy has been performed for PGT-A (preimplantation genetic testing for aneuploidy). A single, chromosomally normal embryo will be transferred in a subsequent frozen embryo transfer cycle per routine. Implantation rates and pregnancy outcomes will be assessed.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Other
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 42 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Major Inclusion Criteria for participants:
- •Patients undergoing IVF stimulation cycle with plan for subsequent frozen embryo transfer (FET)
- •Patients electing preimplantation genetic testing for aneuploidy (PGT-A)
- •Couples electing single embryo transfer (SET)
Exclusion Criteria
- •for participants:
- •All patients who do not voluntarily give their written consent for participation
- •Under 18 years old, above 42 years old
- •Maximum day 3 Follicle stimulating hormone (FSH) level of 12 or higher
- •Anti-mullerian hormone (AMH) level less than 1.0 g/mL, tested within previous year
- •Total basal antral follicle count less than 6 follicles
- •Failed more than one previous FET cycle
- •Use of oocyte donation
- •Use of gestational carrier
- •Presence of hydrosalpinges that communicate with endometrial cavity
- •Diagnosis of endometrial insufficiency: prior cycle with maximal endometrial thickness ≤ 6mm, abnormal endometrial pattern (failure to attain a trilaminar appearance), persistent endometrial fluid
- •Uncorrected uterine factor infertility (uterine anomaly, submucosal myomas, uterine septum)
- •Single gene disorder chromosomal rearrangement requiring a more detailed embryonic genetic analysis
- •Male partner with <100,000 total motile spermatozoa per ejaculate (donor sperm is acceptable)
- •Use of surgical procedures to obtain sperm
- •Couples undergoing IVF for fertility preservation with no immediate plan for subsequent FET (embryo banking)
- •Sex selection
- •Personal history of repeated pregnancy loss (two or more unexplained clinical losses defined by presence of fetal heartbeat)
Arms & Interventions
Vitrification via slush nitrogen
Blastocyst stage embryos will be vitrified via slush nitrogen
Intervention: Vitrification via slush nitrogen (Other)
Vitrification via liquid nitrogen
Blastocyst stage embryos will be vitrified via conventional liquid nitrogen. This is the current standard of care.
Outcomes
Primary Outcomes
sustained implantation rate
Time Frame: approximately 8 weeks gestation age
fetal heart beat present upon discharge at 8 weeks
Secondary Outcomes
- miscarriage rate(1-8 months dependent on gestational age of loss)
- live birth rate(9 months)
- clinical pregnancy rate(usually by 5 weeks gestational age)